EMA EC quorum SOP – Clinical Research Made Simple https://www.clinicalstudies.in Trusted Resource for Clinical Trials, Protocols & Progress Fri, 08 Aug 2025 19:23:20 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.1 SOP for EC Quorum and Conflict of Interest Handling https://www.clinicalstudies.in/sop-for-ec-quorum-and-conflict-of-interest-handling/ Fri, 08 Aug 2025 19:23:20 +0000 ]]> https://www.clinicalstudies.in/sop-for-ec-quorum-and-conflict-of-interest-handling/ Read More “SOP for EC Quorum and Conflict of Interest Handling” »

]]>
SOP for EC Quorum and Conflict of Interest Handling

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.Clinicalstudies.in/SOP-for-EC-Quorum-and-Conflict-of-Interest-Handling”
},
“headline”: “SOP for Ethics Committee Quorum and Conflict of Interest Handling”,
“description”: “This SOP describes regulatory-compliant procedures for managing Ethics Committee (EC)/IRB quorum requirements and handling conflicts of interest, in alignment with ICH GCP, WHO, FDA, EMA, and CDSCO standards.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for EC Quorum and Conflict of Interest Handling

Department Clinical Research
SOP No. CR/ETH/009/2025
Supersedes NA
Page No. 1 of 20
Issue Date 26/08/2025
Effective Date 01/09/2025
Review Date 01/09/2026

Purpose

The purpose of this SOP is to define the procedures for ensuring that Ethics Committee (EC)/Institutional Review Board (IRB) meetings meet quorum requirements and for managing conflicts of interest (COI) among members. This guarantees unbiased decision-making, participant safety, and compliance with international and local regulatory requirements.

Scope

This SOP applies to all EC/IRB members, secretariat staff, investigators, and sponsors involved in clinical trials reviewed by the EC/IRB. It covers quorum establishment, conflict of interest disclosure, member recusal, documentation, and record-keeping.

Responsibilities

  • EC/IRB Chairperson: Ensures quorum is met before review or approval of any protocol and manages COI declarations.
  • EC/IRB Secretariat: Maintains attendance logs, COI declarations, and meeting minutes.
  • EC/IRB Members: Disclose any conflict of interest prior to participation in protocol review.
  • Quality Assurance Officer: Verifies compliance with quorum and COI handling requirements.
  • Head of Clinical Research: Oversees adherence to SOP at institutional level.

Accountability

The EC/IRB Chairperson is accountable for ensuring that all meetings adhere to quorum and COI handling requirements. Any deviation may render decisions invalid and result in regulatory non-compliance.

Procedure

1. Quorum Requirements
A quorum is defined as at least 5 voting members, including at least one lay person, one member with medical/scientific expertise, and one member independent of the institution (as per ICH GCP and national guidelines).
Meetings without quorum shall be rescheduled; decisions made without quorum are invalid.

2. Attendance Recording
EC/IRB Secretariat records attendance at each meeting.
Attendance log must include name, designation, role (voting/non-voting), and signature.

3. Conflict of Interest (COI) Disclosure
All members must declare COI before discussion of any protocol where they have financial, academic, or personal interest.
Declarations must be documented in the COI Register (Annexure-2).

4. COI Management
Members with COI shall leave the meeting room during discussion and decision-making.
Their absence and recusal must be recorded in meeting minutes.

5. Documentation and Record Keeping
Secretariat files attendance logs, COI declarations, and minutes in EC/IRB records.
Records are archived in compliance with ICH GCP and local requirements.

Abbreviations

  • SOP: Standard Operating Procedure
  • EC: Ethics Committee
  • IRB: Institutional Review Board
  • COI: Conflict of Interest
  • ICH: International Council for Harmonisation
  • GCP: Good Clinical Practice
  • QA: Quality Assurance

Documents

  1. EC/IRB Attendance Log (Annexure-1)
  2. Conflict of Interest Declaration Register (Annexure-2)
  3. EC/IRB Meeting Minutes Template (Annexure-3)

References

  • ICH E6(R2) Good Clinical Practice
  • US FDA 21 CFR Part 56 – IRB Requirements
  • EMA Clinical Trial Regulation (EU No. 536/2014)
  • WHO Operational Guidelines for Ethics Committees
  • CDSCO Clinical Trial Rules, India (2019)

Version: 1.0

Approval Section

Prepared By Rajesh Kumar, EC/IRB Secretariat Officer
Checked By Sunita Reddy, QA Officer
Approved By Dr. Anil Sharma, EC/IRB Chairperson

Annexures

Annexure-1: EC/IRB Attendance Log

Date Member Name Designation Role Signature
05/09/2025 Dr. Meera Joshi Clinician Voting Signed
05/09/2025 Mr. Ravi Kumar Lay Member Voting Signed

Annexure-2: Conflict of Interest Declaration Register

Date Member Name Protocol No. Declared Interest Action Taken
05/09/2025 Dr. Anil Sharma CTP-2025-05 Consultant for sponsor Recused

Annexure-3: EC/IRB Meeting Minutes Template

Date Protocol No. Discussion Summary Decision Remarks
05/09/2025 CTP-2025-05 Protocol reviewed, quorum achieved Approved With condition: SAE reporting within 24 hrs

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
26/08/2025 00 Initial version New SOP creation Head, Clinical Research

For more SOPs visit: Pharma SOP

]]>